高水平开放实现新突破。中新合作、开放创新综合试验、自贸片区等重大开放平台叠加优势持续彰 显，生物医药全产业链开放创新发展试点落地实施，自贸区制度创新评价排名首进全国前十，博世智能 驾控、罗氏诊断、礼来、安踏等一批重大项目签约落地、开工开业。 昨天（2月25日），苏州工业园区召开2025年度高质量发展总结暨作风建设大会，动员全区上下提 振精气神、鼓足拼搏劲，以实干实绩推动"十五五"开好局、起好步，加快建设开放创新的世界一流高科 技园区。 会议指出，园区要力争到"十五五"末，地区生产总值突破5000亿元，工业总产值突破1万亿元。围 绕实现全年目标，全区上下要加压实干奋进，全力冲刺一季度地区生产总值增长6%，力争全年地区生 产总值增长5.5%以上。 过去一年，园区顺利完成全年目标任务，实现"十四五"圆满收官。在苏州市2025年度高质量发展综 合考核中，园区获得第一等次第一名。高质量发展迈上新台阶，园区全年实现地区生产总值4163亿元、 增长5.5%，规上工业总产值7362亿元、增长6.1%，占全市15%；一般公共预算收入432.6亿元，进出口 总额首次突破8000亿元，增长20.8%；实际使用外资19.2亿美元，外 ...

Core Insights - The article highlights the emerging trend of foreign investment in China's technology sector, particularly focusing on eight "dark horse" companies that have attracted significant foreign capital due to their alignment with national policies and strong R&D capabilities [1][3][7] Group 1: Foreign Investment Trends - In the first nine months of 2023, nearly 49,000 new foreign-invested enterprises were established in China, marking a year-on-year increase of 16.2%, despite a slight decline in overall foreign capital utilization [1] - High-tech industries, particularly e-commerce services and aerospace manufacturing, saw foreign investment growth rates of 155.2% and 38.7%, respectively [1] Group 2: Selection of Companies - The eight companies that attracted foreign investment are all positioned in hard technology sectors, aligning with the Chinese government's 2025 foreign investment stabilization policy [3] - Notable investments include Bosch's 10 billion yuan project in Suzhou for smart driving technology and Roche's 380 million Swiss franc investment in a research and production base in Suzhou, focusing on medical devices [3][4] Group 3: R&D Capabilities - All eight companies have established R&D centers in China, receiving official recognition as foreign R&D centers, which enhances their attractiveness to foreign investors [3][4] - Companies like Trumpf and Crown Bioscience have developed comprehensive R&D platforms that cater to both local and global markets, demonstrating a strong commitment to innovation [4][5] Group 4: Local Supply Chain Integration - The companies have built robust local supply chains, ensuring they are not merely "shell R&D" operations but are deeply rooted in the Chinese market [5][6] - For instance, companies like Suzhou New Wave Biotechnology and Mettler-Toledo have integrated their R&D and production capabilities to respond quickly to local market demands [5] Group 5: Investment Confidence - Significant investments from foreign companies, such as Danfoss's 2.7 billion yuan investment in a zero-carbon industrial park, reflect strong confidence in the Chinese market [6] - The Chinese government's policies, including the removal of restrictions on foreign investment companies and support for innovative medical products, provide a stable environment for long-term foreign investment [6][7]

Group 1 - The core viewpoint is that multinational companies are not merely relocating production to China but are strategically reallocating global innovation resources, emphasizing future-oriented choices [3][5][6] - There is a notable trend of increased foreign investment in R&D in China, with 631 foreign R&D centers established in Shanghai and 221 in Beijing as of September and January respectively [3] - Significant investments include Bosch's plan to invest approximately 10 billion yuan in Suzhou for smart driving technology and Danfoss's additional investment of 2.7 billion yuan in Jiaxing for a new factory [3][4] Group 2 - China is recognized not only for its large consumer market but also as a vibrant market where new trends and demands often emerge first, making it essential for companies to integrate into this market for greater development opportunities [4] - The country has become a leader in several advanced technology fields, with Bayer reporting that 15% of its global innovative health products come from China, the highest for any single market [4][5] - The investment in China is seen as a forward-looking strategy rather than just a localization tactic, with many companies establishing R&D centers to enhance their global competitiveness [5][6] Group 3 - China's robust industrial system and rich application scenarios contribute to its increasing importance in the global innovation chain, with R&D expenditure intensity surpassing the EU average and a rise in global innovation index ranking to 10th [4][5] - The supportive environment for innovation in China, characterized by high acceptance of new technologies by government, enterprises, and consumers, fosters a positive cycle between technology and market [5][6] - The ongoing optimization of the business environment, including better protection of intellectual property rights and equal treatment for foreign enterprises, enhances the attractiveness of China for foreign investment [5][6]

Group 1 - The core viewpoint is that multinational companies are increasing investments in Suzhou, Jiangsu, driven by the rapidly developing Chinese market, which presents new opportunities for global enterprises [1][3]. - Bosch Group signed an agreement with Suzhou Industrial Park to invest 10 billion yuan over five years to establish an intelligent driving control industry innovation project [3]. - Roche Diagnostics announced an investment of 380 million Swiss francs in Suzhou to build a new production and R&D base for reagents and instruments, marking Roche's largest single investment project in China [3]. Group 2 - In the first half of the year, Suzhou utilized foreign capital amounting to 4.585 billion USD, indicating stable growth [5]. - The Director of the Foreign Investment Department of Suzhou's Commerce Bureau emphasized the importance of helping local manufacturing enterprises enhance their supply chains and innovate, thereby exporting China's application scenarios [6].